Literature DB >> 7698844

Cutaneous biopsies for diagnosis of histoplasmosis in an HIV patient.

N Petit, E Bonnet, F Chapel, P Bensa, H Gallais, G Lebreuil.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 7698844     DOI: 10.1007/bf01715505

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  7 in total

Review 1.  Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Authors:  L J Wheat; P A Connolly-Stringfield; R L Baker; M F Curfman; M E Eads; K S Israel; S A Norris; D H Webb; M L Zeckel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

Review 2.  Histoplasmosis and AIDS.

Authors:  J R Graybill
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

Review 3.  Disseminated histoplasmosis in patients infected with human immunodeficiency virus.

Authors:  G A Sarosi; P C Johnson
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

4.  Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens.

Authors:  L J Wheat; R B Kohler; R P Tewari
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

5.  Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.

Authors:  P K Sharkey-Mathis; J Velez; R Fetchick; J R Graybill
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-07

6.  Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.

Authors:  P C Johnson; N Khardori; A F Najjar; F Butt; P W Mansell; G A Sarosi
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

Review 7.  Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome.

Authors:  J Eidbo; R L Sanchez; J A Tschen; K M Ellner
Journal:  Am J Surg Pathol       Date:  1993-02       Impact factor: 6.394

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.